Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesalamine Granules in IBS-D
NCT01177410Phase 2Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Jul 2010
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Salcrozine in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by Valeant Pharmaceuticals. Started Jul 2010; status: completed.
02
Drugs
Salcrozine
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT01177410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01177410.